ONCOPROTEIN V-MYB AND RETINOIC ACID RECEPTOR-ALPHA ARE MUTUAL ANTAGONISTS

Citation
K. Zemanova et J. Smarda, ONCOPROTEIN V-MYB AND RETINOIC ACID RECEPTOR-ALPHA ARE MUTUAL ANTAGONISTS, Blood cells, molecules, & diseases, 24(11), 1998, pp. 239-250
Citations number
49
Categorie Soggetti
Hematology
ISSN journal
10799796
Volume
24
Issue
11
Year of publication
1998
Pages
239 - 250
Database
ISI
SICI code
1079-9796(1998)24:11<239:OVARAR>2.0.ZU;2-Z
Abstract
The process of hematopoiesis is critically dependent on correct intera ctions of multiple regulatory molecules and transcription factors. We have studied the interactions of the v-Myb and retinoic acid receptor proteins which have opposing effects on hematopoiesis, While v-myb act s as a transforming oncogene preventing differentiation of monoblasts to macrophages, RAR alpha functions as an anti-oncogene arresting the growth of v-myb-transformed cells and allowing their final myeloid dif ferentiation steps to occur. We found that the retinoic acid receptor alpha inhibits v-Myb transformation by suppressing the expression of v -Myb target genes typified by the mim-1 gene. Conversely, v-Myb protei n interferes with RAR alpha transactivation function as well as with r etinoic acid-induced apoptosis of HL-60 cells. These results demonstra te that retinoic acid receptor and v-Myb proteins act in antagonistic ways and reciprocally modify each other's functions. (C) 1998 Academic Press.